Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Anemia, Hypoplastic

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Anemia, Hypoplastic in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Research Excerpts

ExcerptRelevanceReference
"Acquired aplastic anemia is an immune-mediated disease, in which T cells target hematopoietic cells; at presentation, the bone marrow is replaced by fat."1.43PPARĪ³ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function. ( Chen, J; Desierto, MJ; Feng, X; Kajigaya, S; Keyvanfar, K; Li, J; Malide, D; Muranski, P; Sato, K; Young, NS, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, K1
Feng, X1
Chen, J1
Li, J1
Muranski, P1
Desierto, MJ1
Keyvanfar, K1
Malide, D1
Kajigaya, S1
Young, NS1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Anemia, Hypoplastic

ArticleYear
PPARĪ³ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.
    Haematologica, 2016, Volume: 101, Issue:1

    Topics: Anemia, Aplastic; Animals; Benzhydryl Compounds; Bone Marrow; Epoxy Compounds; Immunity, Cellular; M

2016